MTOR and cancer: The hallmarks of cancer pathway PI3K_AKT_MTOR and epithelial_mesenchymal_ transition were significantly enriched for A1 and A2, respectively, whereas the glycolysis and IL2_STAT5_oncogenic pathways were enriched for subgenotype D3 and genotype E, respectively.